Skip to main content

Re-Emergence of Childhood Respiratory Infections in Adults (RSV&Pertussis)

B: Pertussis in Adults

  • Chapter
Emerging Issues and Controversies in Infectious Disease

Part of the book series: Emerging Infectious Diseases of the 21st Century ((EIDC))

  • 780 Accesses

Pertussis (whooping cough) remains an uncontrolled infectious disease despite the institution of universal vaccination in children since the early 1940s. In fact in many developed countries in North America and Europe pertussis has been increasing since 1980. In the United States the number of annually reported cases has increased sixfold since 1980, with 11,647 cases reported in 2003, despite vaccination compliance of more than 80% of young children.1 Pertussis whole-cell vaccine was introduced in Canada in 1943, and the incidence of whooping cough declined by 90% over the subsequent 40 years.2 However, it has increased again in the early 1990s and has remained high since then. The incidence of whooping cough has also increased in recent years in Norway, especially in older children and adults, and in 2004 it was 168 cases per 100,000 of the population.3 The reported incidence rates probably underestimate the true burden of the disease because of incomplete reporting and lack of recognition of the illness.4,5

Young children with pertussis are more easily diagnosed because of presentations with whooping cough, paroxysmal cough episodes followed by an audible inspiratory whoop and sometimes vomiting. Although most children have a persistent but benign illness, serious sequale may occur in infants such as pneumonia, seizures, encephalopathy, and death. Infants can also present with cough and apneic episodes. Immunized infants, older children, adolescents, and adults do not exhibit whooping cough but may have prolonged cough for several weeks.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Hewlett, E.L., Edwards, K.M., (2005) Pertussis–not just for kids. N. Engl. J. Med. 352:1215–1222.

    Article  CAS  PubMed  Google Scholar 

  2. Galonis, E., King, A.S. Varughese, P., Halperin, S.A., (2006) Changing epidemiology and emerging risk groups for pertussis. C M A J 174:451–452.

    Google Scholar 

  3. Dudman, S.G., Troseid, M., Jonassen, T.O., Steinbak, K.M., (2006) Whooping cough – an increasing problem in Norway. Tidss Krift fur Den Norske Laegeforening; 126:305–308.

    Google Scholar 

  4. Deeks, S., DeSemes, G., Boulianne, N., Duval, B., Rochette, L., Dery, P., Halperen, S., (1999) Failure of physicians to consider the diagnosis of pertussis in children. Clin. Infect. Dis. 28:840–846.

    Article  CAS  PubMed  Google Scholar 

  5. Crowcroft, N.S., Stein, C., Duclos, P., Birmingham, M., (2003) How best to estimate the global burden of pertussis? Lancet Infect. Dis. 3:413–418.

    CAS  Google Scholar 

  6. Loeffelholz, M.J., (2003) Bordetella, in Manual of Clinical Microbiology, 8th Edition; Murray, P.R., Baron, E.J., Jorgensen, J.H., Pfaltler. M.A., Yorken, R.H., A S M Press, Washington DC, pp. 780–788.

    Google Scholar 

  7. Cotter, P.A., Miller, J.F., (2001) Bordetella, in:Principles of bacterial pathogenesis, Groisman, E.A. (Ed) Academic Press, San Diego, CA, pp. 619–674.

    Chapter  Google Scholar 

  8. Preston, A., (2005) Bordetella pertussis:the intersection of genomies and pathobiology. C M A J 173:55–62.

    Google Scholar 

  9. Heininger, U., Stehr, K., Schmitt-Grohe, S., Lerenz, C., Rost, R., Christenson, P.D., Uberal, M., Cherry, J.D., (1994) Clinical characteristics of illness caused by Bordetella parapertussis compared with illness caused by Bordetella pertussis. Pediatr. Infect. Dis. J. 13:306–309.

    Article  CAS  PubMed  Google Scholar 

  10. Locht, C., Antoine, R., Raze, d., Mielcarek, N., Hot, D., Lemoine, Y., Mascart, F., (2004) Bordetella pertussis from functional genomics to intranasal vaccination. Int. J. Med. Microbiol. 293:583–588.

    Article  CAS  PubMed  Google Scholar 

  11. Edwards, K.M., (2003) Pertussis an important target for maternal immunization. Vaccine 21:3483–3486.

    Article  CAS  PubMed  Google Scholar 

  12. Stehr, K., Cherry, J.D., Heininger, U., Schmitt-Grohe, S., Uberall, M., Laussucq, S., Eckhardt, T., Meyer, M., Engelhardt, R., Christensen, P., (1998) A comparative efficay trial in Germany in infants who received either the Lederle/Takeda acellular pertussis component DTA (DtaP) vaccine, the Lederle whole- cell component DT P vaccine or DT vaccine. Pediatrics 101:1–11.

    Article  CAS  PubMed  Google Scholar 

  13. Cherry, J.D., Chang, S.J., Klein, D., Lee, M., Barenkamp, S., Bernstein, D., Edelman, R., Decker, M.D., Greenberg, D.P., Keitel, W., Treanor, J., Ward, J.I., (2004) Prevalence of antibody to Bordetella pertussis antigens in serum specimens obtained from 1793 adolescents and adults. Clin. Infect. Dis. 39:1715–1718.

    Article  PubMed  Google Scholar 

  14. Olin, P., Hallander, H.O., Gustafsson, L., Reizenstein, E., Storsacter, J., (2001) How to make sense of pertussis immunogenicity data. Clin. Infect. Dis. 33 (Suppl.4):S288–S291.

    Article  CAS  PubMed  Google Scholar 

  15. Edelman, K., He, Q., Mäkinen, J., Sahlberg, A., Haanperä, M., Schuermna, L., Wolter, J., Mertsola, J., (2007) Immunity to pertussis 5 Years after booster immunization during adolescence. Clin Infect. Dis. 44:1271–1277.

    Article  CAS  PubMed  Google Scholar 

  16. Crowcroft, N.S., Pebody, R.C., (2006) Recent developments in pertussis. Lancet 367:1926– 1936.

    Article  PubMed  Google Scholar 

  17. Mills, KH, (2001) Immunity to Bordetella pertussis. Microbes. Infect. 3:655–677.

    Article  CAS  PubMed  Google Scholar 

  18. Wendelboe, AM., van Rie, A, Salmaso, S, Englund, JA (2005) Duration of immunity against pertussis after natural infection or vaccination. Pediatr. Infect. Dis. 24:s58–s61.

    Article  Google Scholar 

  19. Cherry, J.D., Grimprel, E., Guiso, N., Heininger, U., Mentsola, J., (2005) Defining pertussis epidemiology:Clinical, microbiologic and serologic perspectives. Pediatr. Infect. Dis. J. 24 (Suppl 5):S25–S34.

    PubMed  Google Scholar 

  20. Cherry, J.D., (1999) Epidemiological, clinical and laboratory aspects of pertussis in adults. Clin. Infect. Dis. 28(Suppl 2):S112–S117.

    Article  PubMed  Google Scholar 

  21. Orenstein, W.A., (1999) Pertussis in adults:Epidemiology, signs, symptoms and implications for vaccination. Clin. Infect. Dis. 28 (Suppl 2):S147–S150.

    Article  Google Scholar 

  22. Schellekens, J., von Konig, C.H., Gardner, P., (2005) Pertussis sources of infection and routes of transmission in the vaccination era. Pediatr. Infect. Dis. J. 24 (Suppl. 5):S19–S24.

    PubMed  Google Scholar 

  23. Lievano, F.A., Reynolds, M.A., Waring, A.L., Ackelsberg, J., Bisgard, K.M., Sanden, G.N., Guris, D., Golaz, A., Bopp, D.J., Limberger, R.J., Smith, P.F., (2002) Issues associated with and recommendation for using PCR to detect outbreaks of pertussis. J. Clin. Microbiol 40:2801–2805.

    Article  CAS  PubMed  Google Scholar 

  24. Halperin, S.A., (2007) The control of pertuiss – 2007 and beyond. N. Engl. J. Med. 356:110–113.

    Article  CAS  PubMed  Google Scholar 

  25. Advisory Committee on Immunization Practices (ACIP) (2006) Preventing tetanus, diphtheria, and pertussis among adolescents:use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines:recommendations of the Advisory Committee on Immunization Practices (ACIP) MMWR Recommen. Rep. 55 (RR-3):1–34.

    Google Scholar 

  26. Ntezayabo, B., De Serres, G., Duval, B., (2003) Pertussis resurgence in Canada largely caused by a cohort effect. Pediatr. Infect. Dis. 22:22–27.

    Article  Google Scholar 

  27. Mastrantonio, P., Spigagha, P., van Oirschot, H., van der Heide, H.G., Heuvelman, K., Stefanelli, P., Mooi, F.R., (1999) Antigenic variants in Bordetalla pertussis strains isolated from vaccinated and unvaccinated children. Microbiology; 145:2069–2075.

    Article  CAS  PubMed  Google Scholar 

  28. Tozzi, A.E., Celentano, L.P., Ciofi degli Atti, M.L., Salmaso, S., (2005) Diagnosis and management of pertussis. C M A J: 172:509–515.

    Google Scholar 

  29. Yaari, E., Yafe-Zimerman, Y., Schwartz, S.B., Slater, P.E., Schvartzman, P., Andoren, N., Branski, D., Kerem, E., (1999) Clinical manifestation of Bordetella pertussis infection in immunized children and young adults. Chest: 115:1254–1258.

    Article  CAS  Google Scholar 

  30. Kosters, K., Riffelmann, M., Wirsing vonKonig, C.H., (2001) Evaluation of a real-time PCR assay for detection of Bordetella pertussis and B. parapertussis in clinical samples. . J. Med. Microbiol. 50:436–440.

    CAS  PubMed  Google Scholar 

  31. Gilberg, S., Njamkepo, E., Schlumberger, M., Guiso, N, (2002) Evidence of Bordetella pertussis infection in adults presenting with persistent cough in a French area with very high whole-cell vaccine coverage. J. Infect. Dis. 186:415–418.

    Article  PubMed  Google Scholar 

  32. Wirsing von Konig, C.H., Halperin, S., Rifflemann, M., Guiso, N., (2002) Pertussis of adults and infants. Lancet Infect. Dis. 2:744–750.

    Article  Google Scholar 

  33. Pillay, V., Swingler, G., (2003) Symptomatic treatment of the cough in whooping cough. Cochrane Database Syst. Rev. (4):CD 003257.

    Google Scholar 

  34. Widdecombe, J., Shankar, K., (2004) Acute cough in the elderly:aetiology, diagnosis and therapy. Drugs Aging 31:243–258.

    Article  Google Scholar 

  35. Ward, J.I., Cherry I.D., Chang, S.J., Partridge, S., Lee, H., Treanor, J., Greenberg, D.P., Keitel, W., Borenkamp, S., Bernstein, D.I., Edelman, R., Edwards, K., APERT Study Group, (2005) Efficacy of an acellular pertussis vaccine among adolescents and adults. N. Engl. J. Med. 353:1615–1617.

    Article  Google Scholar 

  36. Purdy, K.W., Hoy, J.W., Botterman, M.F., Ward, I.F., (2004) Evaluation of strategies for use of acellular pertussis vaccine in adolescents and adults. A cost - benefit analysis. . Clin. Infect. Dis. 39:20–28.

    Article  PubMed  Google Scholar 

  37. Ward, A., Caro, J., Bassinet, L., Housset, B., O'Brien, J.A., Guiso, N., (2005) Health and economic consequences of an outbreak of pertussis among healthcare workers in a hospital in France. Infect. Control. Hosp. Epidemiol. 26:288–292.

    Article  PubMed  Google Scholar 

  38. Tablan, O.C., Andersen, J, Besser-May, T., Bridges, C., Hayjeh, R., CDC:Healthcare Infection Control Practices Advisory Committee, (2004) Guidelines for preventing healthcare associated pneumonia, 2003:recommendations of CDC and the HealthCare Infection Control Practices Advisory Committee. M M W R: 53(RR-3): 1–36.

    Google Scholar 

  39. Dodhin, H., Crowcroft, N.S., Bramley, J.C., Miller, E., (2002) U.K. Guidelines for use of erythomycin chemoproplylaxis in persons exposed to pertussis. J. Public Helath Med. 24:200–206.

    Article  Google Scholar 

  40. Hodder, S.L., Cherry, J.D., Montimer, E.A. Jr., Ford, A.B., Gombein, J., Papp, K., (2002) Antibody responses to Bordetella pertussis antigens and clinical correlations in elderly community residents. Clin. Infect. Dis. 31:7–14.

    Article  Google Scholar 

  41. Preston, A., Parkhill, J., Maskell, D.J., (2004) The Bordettellae:lessons from genomics. Nat. Rev. Microbiol. 2:379–390.

    Article  CAS  PubMed  Google Scholar 

  42. Forsyth, K.D., Campins-Marti, Caro, J., Cherry, J.D., Greenberg, D., Guiso, N., Heininger, U., Schellekens, J., Tan, T., Wirzing von Konig, C.H., Plotkin S., for the Global Pertussis Initiative, (2004) New pertussis vaccination strategies beyond infancy:Recommendation by the Global Pertussis Initiative. Clin. Infect. Dis. 39:1802–1809.

    Article  PubMed  Google Scholar 

Download references

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

(2009). Re-Emergence of Childhood Respiratory Infections in Adults (RSV&Pertussis). In: Fong, I.W. (eds) Emerging Issues and Controversies in Infectious Disease. Emerging Infectious Diseases of the 21st Century. Springer, New York, NY. https://doi.org/10.1007/978-0-387-84841-9_6

Download citation

  • DOI: https://doi.org/10.1007/978-0-387-84841-9_6

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-0-387-84840-2

  • Online ISBN: 978-0-387-84841-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics